MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

21 Oct 2026 Evaluate
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Dr. Reddy’s Receives DCGI Approval for Zytorvi® (toripalimab) in Advanced Esophageal Squamous Cell Carcinoma, Its Second Approved Indication in India’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.00
Dr. Reddys Labs. 1239.00
Cipla 1328.90
Lupin 1916.80
Zydus Lifesciences 1138.05
View more..